Upload
drbarai
View
892
Download
2
Embed Size (px)
Citation preview
Management of Pulmonary Embolism in Emergency Department
Dr. A. Barai MBBS, MRCS Ed, MSc (Critical acre)
Registrar in Emergency Medicine
• 26 years old male• Otherwise fit and healthy
HOPC:• Collapsed inside the house while standing• Unresponsive for 5 minutes• Diaphoretic and tachypnoeic• Computer engineer by profession• Has been in front of the computer for 18 hours a day for a
month without any break
Case 1Case 1
O/E:• Pulse 128/min, regular• BP: 126/72 mmHg• RR 32/min• Sats: 90% RA• ECG: Sinus tachycardia. S1Q3T3 pattern• ABG: PO2= 56 mmHg• CXR: Normal• Doppler USS: DVT in left leg.• VQ scan: Perfusion defect in right lower lobe.
Treatment:• Unfractionated heparin IV followed by• Oral Warfarin
Introduction• Pulmonary embolism (PE) is a medical emergency
where pulmonary artery or its branches are blocked with embolic substances most commonly blood clots
• Most cases are not life threatening.
• Incidence: 600,000/year in USA
• Mortality rate: 50,000 to 200,000/yr in US
Types of PE• Massive PE: Acute PE with obstructive shock or SBP
<90 mmHg for > 15 minutes or shock
• Sub-massive PE: Acute PE without systemic hypotension (SBP ≥90 mm Hg) but with either RV dysfunction or myocardial necrosis
• Non-massive or low risk PE: None of the above severe features.
Jaff MR, et al. (2011)
Diagnosis• Risk stratification
• Clinical examination
• Bed side tests
• Laboratory tests
• Imaging techniques
Risk factors• Alteration of blood flow:
– Prolonged immobilisation, – Obesity, – Pregnancy, – Cancer
• Factors in blood vessel wall: – Surgery, – Catheterisation.– Trauma
• Hypercoagulable states: – Estrogen containing OCP, – Genetic thrombophilia (Factor V Leiden deficiency, Protein C and
Protein S deficiency, antithrombin III deficiency etc.), – Acquired thrombophilia (antiphospholipid syndrome, nephrotic
syndrome, paroxysmal nocturnal hemoglobinuria)
Risk stratification
• PERC Rule
• Wells score for PE
• Modified Geneva score for PE
PERC
PERC
Kline JA, Mitchell AM, Kabrhel C, et al. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost 2004;2:1247–55.
Wells score for PE
Investigations• Bed side tests: ECG, ABG
• Blood tests: D-dimer, FBC, Troponin, UEC
• Imaging techniques: Ultrasound/ Doppler scan, Chest xray, CTPA, V/Q scan, Echocardiogram
ABG findings in PE
• pH= ↑ • PaO2= ↓• PaCO2= ↓• HCO3= Normal• Aa gradient= Large
Aa gradient= PAO2- PaO2
Chest xray• Mostly normal findings
• Done to exclude other pathology
• Plural effusion
• Specific signs:- Hampton’s hump- Westermark sign
Hampton’s hump
Westermark sign
ECG findings in PE• Normal sinus rhythm
• Sinus tachycardia
• Tall peaked T waves in V1- V4
• S1Q3T3 pattern: Not specific. Can be seen in any Cor pulmonale syndrome
• RBBB
S1Q3T3 pattern ECG
D-dimer in PE• D-dimer is a type of Fibrin degradation product
• Can be raised due to a number of reasons
• Negative D-dimer rules out PE/DVT in 98% cases
• False positive D-dimer: infection, pregnancy, renal failure, post-operative
Echocardiogram in PE
Doppler USS
CTPAIndications:
- Suspected PE
Contra-indications:- Renal failure- Pregnancy- Allergy to radio-contrast
Procedure:- Radioactive iodine administered IV- CT scan performed
Ventilation-perfusion scanIndications:
- Renal failure- Pregnancy
Procedure:- Ventilation scan with Xenon inhalation- Perfusion scan with Tc99m labelled radioactive dye infusion- Scan V/Q- Result: unmatched V/Q
Pitfalls of CTPA• Average radiation exposure is 12.4-31.8 mSV.
• This was estimated to increase the risk of breast cancer by 1.004 to 1.042 and lung cancer from 1.005 to 1.076.
• The excess risk of cancer for individuals over 55 would be less than 1%;
• In a young 20-year-old woman this would be estimated to increase the relative lifetime risk of breast or lung cancer by 1.7 to 5.5%.
(Hurwitz et al. 2007)
Treatment options• Symptomatic treatment:
– ABCD approach– Oxygen– Analgesia
• Anticoagulation:– IV Heparin– S/C LMWH eg Enoxaparine, Dalteparine– Oral Warfarin
• IVC filter: If there is contra-indications for anti-coagulation
• Thrombolysis: tPA eg Alteplase, Tenectaplase
• Surgical procedures: Pulmonary embolectomy
Treatment options
• Massive PE: Thrombolysis/embolectomy
• Sub-massive PE: Strongly consider thrombolysis/embolectomy but need to balance risk of bleeding
• Non-massive PE: Anticoagulation
Thrombolysis• Indications:
– Massive PE– Sub-massive PE where risk of bleeding low
• Contraindications:– Bleeding, recent stroke, HI, current GI bleeding, bleeding
PUD, surgery within 7 day, prolonged CPR
• Drugs:– Alteplase 100mg IV: 15mg IV stat followed by 85mg over
2 hours– Followed by Heparin infusion
Anticoagulation
• IV Heparin: – 80 units/kg bolus followed by – 18 units/kg infusion
• Monitor APTT 60-90 sec
• Side effects: – HITS (Heparin induced thrombocytopenia syndrome):
paradoxical hypercoagulable state leads to clots– Bleeding
Dilemma
• Thrombolysis in normotensive patients with acute PE was associated with increased mortality (Riera-Mestre, A.et al. 2012).
• European Society of Cardiology (ESC) guidelines suggest assessing for RV dysfunction (using echocardiography, CT or B-type natriuretic peptide) or ischaemia (troponin) to aid risk stratification.(Torbicki A, 2008).
• Use of tenecteplase in submassive PE (PEITHO) observed rates of major bleeding of 6.3% and Intracranial haemorrhage of 2%.
Dilemma1:Dilemma1: Submassive PE
• Major bleeding occurred in >50% of patients receiving thrombolysis within 1 week of surgery and in 20% of patients thrombolysed 1–2 weeks postoperatively. (Condliffe, R. et al. 2014).
• Thrmbolysis is a relative contraindication in these patient groups. (American College of Chest Physicians Guidelines)
Dilemma2:Dilemma2: Recent surgery
• Thrombolytic agents for PE should be administered peripherally.
• Alteplase: 10mg IV bolus followed by 90mg over 1-2 hours.
• Alternative drugs: tenecteplase, streptokinase, urokinase
• If already on LMWH: Start IV Heparin 18 hours after last dose of LMWH
Dilemma3Dilemma3::Patient on LMWH
• Echocardiogram to confirm right heart strain
• Thrombolysis: Alteplase 50mg IV bolus (Kadner et al. 2008)
• Emergency pulmonary embolectomy
• If cause of arrest unclear: No thrombolysis
Dilemma4:Dilemma4: Arrest or periarrest
• If a patient with acute PE fails to respond to initial anticoagulation, with worsening cardiovascular instability and/or respiratory failure, then thrombolysis should be considered.
• In the MAPPET-3 study of submassive PE, delayed thrombolysis was performed in 23% of patients treated initially with heparin, with no difference in mortality compared with patients receiving up-front thrombolysis.
(Konstantinides et al 2002)
Dilemma5:Dilemma5: Recent PE failed Rx
AnticoagulationLow molecular weight Heparin (LMWH)
Enoxaprin (Clexane): S/C- 1.5mg/kg/24 hours Or 1mg/kg/12 hours- 1 mg/kg/24 hours in renal impairment
Duration: 6 to 9 months
Side effect: Low HITS
Anticoagulation• Vitamin K antagonist
• Warfarin: – 5mg PO initial dose– Check regular INR 2-3
• Side effects:– Bleeding– Unusual bruises– Headache
IVC filter
Indications:- DVT with massive pulmonary embolus- Recurrent PE not treatable with anticoagulation- Absolute contra-indications for anti-coagulation- Trauma patients
PE in Pregnancy• All three components of Virchow’s triad are affected during
pregnancy
• D-dimer has high negative predictive value. False positive result is common
• V/Q scan is preferred technique
• CTPA can be done if VQ is inconclusive
• Preferred treatment option: LMWH
• Warfarin is contraindicated
Prevention of PE• Control of obesity
• Stop smoking
• Stockings
• Heparin: 5000 units/day IV
• Enoxaprin: 40 mg/day S/C
And finally…
PE is often over-diagnosed;
PE is often under-diagnosed;
Both conditions result in increased cost, morbidity, mortality and medico-legal issues.
References• Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med. 2010 Jul 15;363(3):266-74. doi:
10.1056/NEJMra0907731. Epub 2010 Jun 30
• Bourjeily G, Paidas M, Khalil H, et al. Pulmonary embolism in pregnancy.Lancet. 2010;375:500-512
• Hofman, M. S.; Beauregard, J. -M.; Barber, T. W. et al.(2011). 68Ga PET/CT Ventilation-Perfusion Imaging for Pulmonary Embolism: A Pilot Study with Comparison to Conventional Scintigraphy. Journal of Nuclear Medicine 52 (10): 1513–1519.
• Jaff MR, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011 Apr 26;123(16):1788-830. doi: 10.1161/CIR.0b013e318214914f. Epub 2011 Mar 21. Erratum in: Circulation. 2012 Mar 20;125(11):e495. Circulation. 2012 Aug 14;126(7):e104.
• Mattu, A. PE in pregnancy: A complicated diagnosis. Medscape. August 9, 2010 (Online) URL: http://www.medscape.com/viewarticle/726318
• Pulmonary embolism. Life in the fast lane. (Online). http://lifeinthefastlane.com/education/ccc/pulmonary-embolism/
• Kline JA, Mitchell AM, Kabrhel C, et al. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost 2004;2:1247–55.
• Riera-Mestre A, Jimenez D, Muriel A, et al. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism. J Thromb Haemost 2012;10:751–9.
• Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29:2276–315.
• Condliffe R, Elliot CA, Hughes RJ, et al. Management dilemmas in acute pulmonary embolism. Thorax 2014;69:174–180.
References
• Hurwitz LM, Reiman RE, Yoshizumi TT, et al. Radiation dose from contemporary cardiothoracic multidetector CT protocols with anthropomorphic female phantom: implications for cancer induction. Radiology 2007; 245:742-750.
• Kadner A, Schmidli J, Schonhoff F, et al. Excellent outcome after surgical treatment of massive pulmonary embolism in critically ill patients. J Thorac Cardiovasc Surg 2008;136:448–51.
• Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002;347:1143–50.
References
Thank you!